Appointment of Steven Bloom as Chief Business Officer brings over 35 years of life sciences industry experience, which could enhance Werewolf's strategic development and business initiatives. Bloom's ...
Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to ...
WATERTOWN, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of ...
"Steve brings deep experience in strategic transactions to Werewolf at this critical time," said Daniel J. Hicklin, Ph.D., President and Chief Executive Officer of Werewolf Therapeutics. "Werewolf is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results